OBJECTIVE: To assess prevalence, in-hospital prognostic significance and angiographic correlation of C-reactive protein (CRP) elevation in patients with unstable angina. DESIGN: Prospective observational study. SETTING: Royal Hospital, Muscat, Oman. PATIENTS: 100 patients admitted between July 2008 and January 2009. INTERVENTIONS: Patients with unstable angina and ECG changes without biochemical evidence of necrosis (negative first troponin T), had CRP measured at admission by rate nephelometry (≥10 mg/l abnormal). MAIN OUTCOME MEASURES: In-hospital cardiac events and severity of coronary artery disease (CAD) in patients with and without CRP elevation. RESULTS: 42% had CRP elevation ≥10 mg/l (Group I), and 58% had levels <10 mg/l (Group II). When compared with Group II, Group I patients had more anginal episodes (mean=4.6±2.5 episodes/patient vs 1.6±2.4; p<0.0001), myocardial infarction (58% vs 17%; p<0.01), in-hospital mortality (9% vs 0%; p=0.03) and severe triple vessel disease (71% vs 24%; p<0.01), and a higher total number of events (86% vs 24%; p<0.0001). Elevated admission CRP as a marker of in-hospital cardiac events showed a sensitivity of 72%, specificity of 88% and positive predictive value of 85%, and, as a marker of significant CAD, showed a specificity of 83% and a positive predictive value of 85%. CONCLUSIONS: Raised admission CRP level is predictive of increased in-hospital cardiac events and severe CAD in patients with unstable angina. CRP can be used to risk-stratify unstable angina patients independent of troponin levels. Patients with abnormal CRP should undergo coronary angiography either on-site or transferred to a centre with catheterisation facility during the index hospital admission.
OBJECTIVE: To assess prevalence, in-hospital prognostic significance and angiographic correlation of C-reactive protein (CRP) elevation in patients with unstable angina. DESIGN: Prospective observational study. SETTING: Royal Hospital, Muscat, Oman. PATIENTS: 100 patients admitted between July 2008 and January 2009. INTERVENTIONS:Patients with unstable angina and ECG changes without biochemical evidence of necrosis (negative first troponin T), had CRP measured at admission by rate nephelometry (≥10 mg/l abnormal). MAIN OUTCOME MEASURES: In-hospital cardiac events and severity of coronary artery disease (CAD) in patients with and without CRP elevation. RESULTS: 42% had CRP elevation ≥10 mg/l (Group I), and 58% had levels <10 mg/l (Group II). When compared with Group II, Group I patients had more anginal episodes (mean=4.6±2.5 episodes/patient vs 1.6±2.4; p<0.0001), myocardial infarction (58% vs 17%; p<0.01), in-hospital mortality (9% vs 0%; p=0.03) and severe triple vessel disease (71% vs 24%; p<0.01), and a higher total number of events (86% vs 24%; p<0.0001). Elevated admission CRP as a marker of in-hospital cardiac events showed a sensitivity of 72%, specificity of 88% and positive predictive value of 85%, and, as a marker of significant CAD, showed a specificity of 83% and a positive predictive value of 85%. CONCLUSIONS: Raised admission CRP level is predictive of increased in-hospital cardiac events and severe CAD in patients with unstable angina. CRP can be used to risk-stratify unstable anginapatients independent of troponin levels. Patients with abnormal CRP should undergo coronary angiography either on-site or transferred to a centre with catheterisation facility during the index hospital admission.
Authors: D Katritsis; S Korovesis; E Giazitzoglou; J Parissis; P Kalivas; M M Webb-Peploe; J P Ioannidis; A Haliassos Journal: Clin Chem Date: 2001-05 Impact factor: 8.327
Authors: Sidney C Smith; Ted E Feldman; John W Hirshfeld; Alice K Jacobs; Morton J Kern; Spencer B King; Douglass A Morrison; William W O'Neil; Hartzell V Schaff; Patrick L Whitlow; David O Williams; Elliott M Antman; Cynthia D Adams; Jeffrey L Anderson; David P Faxon; Valentin Fuster; Jonathan L Halperin; Loren F Hiratzka; Sharon Ann Hunt; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel Journal: Circulation Date: 2006-02-21 Impact factor: 29.690
Authors: Stefanos G Foussas; Michael N Zairis; Anastassios G Lyras; Nikolaos G Patsourakos; Vasilios G Tsirimpis; Kostas Katsaros; Demetrios J Beldekos; Stelios M Handanis; Demetrios Z Mytas; Kostas S Karidis; Paraskevi G Tselioti; Athanasios A Prekates; John A Ambrose Journal: Am J Cardiol Date: 2005-08-15 Impact factor: 2.778
Authors: L M Biasucci; G Liuzzo; R L Grillo; G Caligiuri; A G Rebuzzi; A Buffon; F Summaria; F Ginnetti; G Fadda; A Maseri Journal: Circulation Date: 1999-02-23 Impact factor: 29.690
Authors: Benjamin M Scirica; Christopher P Cannon; Marc S Sabatine; Petr Jarolim; Sarah Sloane; Nader Rifai; Eugene Braunwald; David A Morrow Journal: Clin Chem Date: 2008-12-12 Impact factor: 8.327
Authors: Hans Martin Hoffmeister; Raila Ehlers; Evi Büttcher; Armin Steinmetz; Silke Kazmaier; Uwe Helber; Sebastian Szabo; Martin E Beyer; Ludger Seipel Journal: J Thromb Thrombolysis Date: 2003-02 Impact factor: 2.300